DOCSLIB.ORG

Protease Activity As a Prognostic Factor for Wound Healing in Venous Leg Ulcers (Review)

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Protease Activity As a Prognostic Factor for Wound Healing in Venous Leg Ulcers (Review) View metadata, citation and similar papers at core.ac.uk brought to you by CORE provided by Keele Research Repository Cochrane Library Cochrane Database of Systematic Reviews Protease activity as a prognostic factor for wound healing in venous leg ulcers (Review) Westby MJ, Dumville JC, Stubbs N, Norman G, Wong JKF, Cullum N, Riley RD Westby MJ, Dumville JC, Stubbs N, Norman G, Wong JKF, Cullum N, Riley RD. Protease activity as a prognostic factor for wound healing in venous leg ulcers. Cochrane Database of Systematic Reviews 2018, Issue 9. Art. No.: CD012841. DOI: 10.1002/14651858.CD012841.pub2. www.cochranelibrary.com Protease activity as a prognostic factor for wound healing in venous leg ulcers (Review) Copyright © 2018 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd. Cochrane Trusted evidence. Informed decisions. Library Better health. Cochrane Database of Systematic Reviews T A B L E O F C O N T E N T S HEADER......................................................................................................................................................................................................... 1 ABSTRACT..................................................................................................................................................................................................... 1 PLAIN LANGUAGE SUMMARY....................................................................................................................................................................... 2 BACKGROUND.............................................................................................................................................................................................. 4 OBJECTIVES.................................................................................................................................................................................................. 6 METHODS..................................................................................................................................................................................................... 6 Figure 1.................................................................................................................................................................................................. 9 RESULTS........................................................................................................................................................................................................ 12 Figure 2.................................................................................................................................................................................................. 15 Figure 3.................................................................................................................................................................................................. 16 Figure 4.................................................................................................................................................................................................. 18 Figure 5.................................................................................................................................................................................................. 19 Figure 6.................................................................................................................................................................................................. 20 Figure 7.................................................................................................................................................................................................. 20 DISCUSSION.................................................................................................................................................................................................. 21 AUTHORS' CONCLUSIONS........................................................................................................................................................................... 22 ACKNOWLEDGEMENTS................................................................................................................................................................................ 22 REFERENCES................................................................................................................................................................................................ 23 CHARACTERISTICS OF STUDIES.................................................................................................................................................................. 35 DATA AND ANALYSES.................................................................................................................................................................................... 58 Analysis 1.1. Comparison 1 Protease activity continuous, Outcome 1 t-test assocation of protease level and healing 59 (dichotomous)....................................................................................................................................................................................... Analysis 1.2. Comparison 1 Protease activity continuous, Outcome 2 t-test association of protease level and healing: high (≥ 1 60 cmD/week) vs low (< 1 cmD/week) healing.......................................................................................................................................... Analysis 1.3. Comparison 1 Protease activity continuous, Outcome 3 Correlation coeGicients: protease levels and change in 60 size.......................................................................................................................................................................................................... Analysis 2.1. Comparison 2 Protease activity dichotomous, Outcome 1 Association of healing with elevated protease level; by 61 protease modulating (PM) intervention.............................................................................................................................................. APPENDICES................................................................................................................................................................................................. 62 Figure 8.................................................................................................................................................................................................. 71 Figure 9.................................................................................................................................................................................................. 72 Figure 10................................................................................................................................................................................................ 73 Figure 11................................................................................................................................................................................................ 74 Figure 12................................................................................................................................................................................................ 75 Figure 13................................................................................................................................................................................................ 76 CONTRIBUTIONS OF AUTHORS................................................................................................................................................................... 78 DECLARATIONS OF INTEREST..................................................................................................................................................................... 78 SOURCES OF SUPPORT............................................................................................................................................................................... 79 DIFFERENCES BETWEEN PROTOCOL AND REVIEW.................................................................................................................................... 79 INDEX TERMS............................................................................................................................................................................................... 79 Protease activity as a prognostic factor for wound healing in venous leg ulcers (Review) i Copyright © 2018 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd. Cochrane Trusted evidence. Informed decisions. Library Better health. Cochrane Database of Systematic Reviews [Prognosis Review] Protease activity as a prognostic factor for wound healing in venous leg ulcers Maggie J Westby1, Jo C Dumville1, Nikki Stubbs2, Gill Norman1, Jason KF Wong3, Nicky Cullum1, Richard D Riley4 1Division of Nursing, Midwifery and Social Work, School of Health Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester Academic Health Science Centre, Manchester, UK. 2Leeds Community Healthcare NHS Trust, St Mary's Hospital, Leeds, UK. 3Manchester Centre for Plastic Surgery and Burns, Wythenshawe Hospital, Manchester University NHS Foundation Trust, Manchester, UK. 4Research Institute for
Load more

Recommended publications
  • Microbial Enzymes and Their Applications in Industries and Medicine
    BioMed Research International Microbial Enzymes and Their Applications in Industries and Medicine Guest Editors: Periasamy Anbu, Subash C. B. Gopinath, Arzu Coleri Cihan, and Bidur Prasad Chaulagain Microbial Enzymes and Their Applications in Industries and Medicine BioMed Research International Microbial Enzymes and Their Applications in Industries and Medicine Guest Editors: Periasamy Anbu, Subash C. B. Gopinath, Arzu Coleri Cihan, and Bidur Prasad Chaulagain Copyright © 2013 Hindawi Publishing Corporation. All rights reserved. This is a special issue published in “BioMed Research International.” All articles are open access articles distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Contents Microbial Enzymes and Their Applications in Industries and Medicine,PeriasamyAnbu, Subash C. B. Gopinath, Arzu Coleri Cihan, and Bidur Prasad Chaulagain Volume 2013, Article ID 204014, 2 pages Effect of C/N Ratio and Media Optimization through Response Surface Methodology on Simultaneous Productions of Intra- and Extracellular Inulinase and Invertase from Aspergillus niger ATCC 20611, Mojdeh Dinarvand, Malahat Rezaee, Malihe Masomian, Seyed Davoud Jazayeri, Mohsen Zareian, Sahar Abbasi, and Arbakariya B. Ariff Volume 2013, Article ID 508968, 13 pages A Broader View: Microbial Enzymes and Their Relevance in Industries, Medicine, and Beyond, Neelam Gurung, Sumanta Ray, Sutapa Bose, and Vivek Rai Volume 2013, Article
    [Show full text]
  • Amyloid-Degrading Ability of Nattokinase from Bacillus Subtilis Natto
    J. Agric. Food Chem. 2009, 57, 503–508 503 Amyloid-Degrading Ability of Nattokinase from Bacillus subtilis Natto †,‡ § § † RUEI-LIN HSU, KUNG-TA LEE, JUNG-HAO WANG, LILY Y.-L. LEE, AND ,†,‡ RITA P.-Y. CHEN* Institute of Biological Chemistry, Academia Sinica, Taipei 115, Taiwan, R. O. C., Institute of Biochemical Sciences, National Taiwan University, Taipei 106, Taiwan, R. O. C., and Department of Biochemical Science and Technology, National Taiwan University, Taipei 106, Taiwan, R. O. C. More than 20 unrelated proteins can form amyloid fibrils in vivo which are related to various diseases, such as Alzheimer’s disease, prion disease, and systematic amyloidosis. Amyloid fibrils are an ordered protein aggregate with a lamellar cross- structure. Enhancing amyloid clearance is one of the targets of the therapy of these amyloid-related diseases. Although there is debate on whether the toxicity is due to amyloids or their precursors, research on the degradation of amyloids may help prevent or alleviate these diseases. In this study, we explored the amyloid-degrading ability of nattokinase, a fibrinolytic subtilisin-like serine protease, and determined the optimal conditions for amyloid hydrolysis. This ability is shared by proteinase K and subtilisin Carlsberg, but not by trypsin or plasmin. KEYWORDS: Nattokinase; amyloid; natto; subtilisin NAT; amyloid degradation; fibril; amyloidosis INTRODUCTION of cardiovascular disease. Dietary supplementation with natto Natto, a fermented food made from boiled soybeans, has suppresses the intimal thickening of arteries and leads to the been eaten for more than 1000 years in Asia. The fermenta- lysis of mural thrombi seen after endothelial injury (12). tion microbe isolated from natto is the Gram-positive Other clinically thrombolytic agents, such as urokinase and endospore-forming bacterium Bacillus subtilis natto (formerly streptokinase, are costly and unstable in the intestinal tract designated Bacillus natto)(1).
    [Show full text]
  • Identification and Phylogenetic Analysis of Keratinase Producing Bacteria SNP1 from Poultry Field
    International Journal of Biotechnology and Biochemistry ISSN 0973-2691 Volume 15, Number 1 (2019) pp. 39-51 © Research India Publications http://www.ripublication.com Identification and Phylogenetic Analysis of Keratinase Producing Bacteria SNP1 from Poultry Field Divya Balakrishnan and Nithadas Sathyadas Padmanabhan Department of Biotechnology, Sree Narayana College, Kollam-691001, Kerala, India. (*Corresponding author) Abstract The study was conduct to select the best promising keratinolytic bacterial strain. A keratinase positive bacterial strain was isolated from the soil samples of poultry field, Attingal, Thiruvananthapuram. Each sample was plated on skim milk agar and feather meal agar plates containing 5 g feather. The well grown isolates which produced the largest clear zone on skimmed milk plate were selected for keratinase assays. Out of 26 bacterial isolates, 7 isolates were selected. Among the selected strain, the best keratinase producing bacterium SNP1was selected for further analysis. The SNP1 potential strain was later confirmed as Bacillus haynessi based on molecular and phylogenetic analysis. The medium components and culture conditions were optimized to enhance keratinase production through optimization. Keratin and feather powder (10g/l) were identified as good substrates for the highest keratinase production. The strain SNP1 resulted maximum enzyme production at 96h of incubation at 37°C and pH 8 under 120 rpm. Therefore, Bacillus hayneisi might be used for large scale production of keratinase for industrial purposes. Keywords: Keratinase, Bacillus sp., Optimization, Enzyme activity, 16SrRNA Keratin is a hard-degrading fibrous and recalcitrant structural protein, which forms the third most abundant polymer in nature after cellulose and chitin (Lene et al ., 2016). In the native state, the feather keratin resists the degradation by proteolytic enzymes such as trypsin and pepsin due to tightpeptide-chains held together by disulfide bridges by means of cysteine residues (Weeranut, 2017; Korniłłowicz-Kowalska and Bohacz, 2011).
    [Show full text]
  • B1–Proteases As Molecular Targets of Drug Development
    Abstracts B1–Proteases as Molecular Targets of Drug Development B1-001 lin release from the beta cells. Furthermore, GLP-1 also stimu- DPP-IV structure and inhibitor design lates beta cell growth and insulin biosynthesis, inhibits glucagon H. B. Rasmussen1, S. Branner1, N. Wagtmann3, J. R. Bjelke1 and secretion, reduces free fatty acids and delays gastric emptying. A. B. Kanstrup2 GLP-1 has therefore been suggested as a potentially new treat- 1Protein Engineering, Novo Nordisk A/S, Bagsvaerd, Denmark, ment for type 2 diabetes. However, GLP-1 is very rapidly degra- 2Medicinal Chemistry, Novo Nordisk A/S, Maaloev, Denmark, ded in the bloodstream by the enzyme dipeptidyl peptidase IV 3Discovery Biology, Novo Nordisk A/S, Maaloev, DENMARK. (DPP-IV; EC 3.4.14.5). A very promising approach to harvest E-mail: [email protected] the beneficial effect of GLP-1 in the treatment of diabetes is to inhibit the DPP-IV enzyme, thereby enhancing the levels of The incretin hormones GLP-1 and GIP are released from the gut endogenously intact circulating GLP-1. The three dimensional during meals, and serve as enhancers of glucose stimulated insu- structure of human DPP-IV in complex with various inhibitors 138 Abstracts creates a better understanding of the specificity and selectivity of drug-like transition-state inhibitors but can be utilized for the this enzyme and allows for further exploration and design of new design of non-transition-state inhibitors that compete for sub- therapeutic inhibitors. The majority of the currently known DPP- strate binding. Besides carrying out proteolytic activity, the IV inhibitors consist of an alpha amino acid pyrrolidine core, to ectodomain of memapsin 2 also interacts with APP leading to which substituents have been added to optimize affinity, potency, the endocytosis of both proteins into the endosomes where APP enzyme selectivity, oral bioavailability, and duration of action.
    [Show full text]
  • Misc Thesisdb Bythesissuperv
    Honors Theses 2006 to August 2020 These records are for reference only and should not be used for an official record or count by major or thesis advisor. Contact the Honors office for official records. Honors Year of Student Student's Honors Major Thesis Title (with link to Digital Commons where available) Thesis Supervisor Thesis Supervisor's Department Graduation Accounting for Intangible Assets: Analysis of Policy Changes and Current Matthew Cesca 2010 Accounting Biggs,Stanley Accounting Reporting Breaking the Barrier- An Examination into the Current State of Professional Rebecca Curtis 2014 Accounting Biggs,Stanley Accounting Skepticism Implementation of IFRS Worldwide: Lessons Learned and Strategies for Helen Gunn 2011 Accounting Biggs,Stanley Accounting Success Jonathan Lukianuk 2012 Accounting The Impact of Disallowing the LIFO Inventory Method Biggs,Stanley Accounting Charles Price 2019 Accounting The Impact of Blockchain Technology on the Audit Process Brown,Stephen Accounting Rebecca Harms 2013 Accounting An Examination of Rollforward Differences in Tax Reserves Dunbar,Amy Accounting An Examination of Microsoft and Hewlett Packard Tax Avoidance Strategies Anne Jensen 2013 Accounting Dunbar,Amy Accounting and Related Financial Statement Disclosures Measuring Tax Aggressiveness after FIN 48: The Effect of Multinational Status, Audrey Manning 2012 Accounting Dunbar,Amy Accounting Multinational Size, and Disclosures Chelsey Nalaboff 2015 Accounting Tax Inversions: Comparing Corporate Characteristics of Inverted Firms Dunbar,Amy Accounting Jeffrey Peterson 2018 Accounting The Tax Implications of Owning a Professional Sports Franchise Dunbar,Amy Accounting Brittany Rogan 2015 Accounting A Creative Fix: The Persistent Inversion Problem Dunbar,Amy Accounting Foreign Account Tax Compliance Act: The Most Revolutionary Piece of Tax Szwakob Alexander 2015D Accounting Dunbar,Amy Accounting Legislation Since the Introduction of the Income Tax Prasant Venimadhavan 2011 Accounting A Proposal Against Book-Tax Conformity in the U.S.
    [Show full text]
  • Serine Proteases with Altered Sensitivity to Activity-Modulating
    (19) & (11) EP 2 045 321 A2 (12) EUROPEAN PATENT APPLICATION (43) Date of publication: (51) Int Cl.: 08.04.2009 Bulletin 2009/15 C12N 9/00 (2006.01) C12N 15/00 (2006.01) C12Q 1/37 (2006.01) (21) Application number: 09150549.5 (22) Date of filing: 26.05.2006 (84) Designated Contracting States: • Haupts, Ulrich AT BE BG CH CY CZ DE DK EE ES FI FR GB GR 51519 Odenthal (DE) HU IE IS IT LI LT LU LV MC NL PL PT RO SE SI • Coco, Wayne SK TR 50737 Köln (DE) •Tebbe, Jan (30) Priority: 27.05.2005 EP 05104543 50733 Köln (DE) • Votsmeier, Christian (62) Document number(s) of the earlier application(s) in 50259 Pulheim (DE) accordance with Art. 76 EPC: • Scheidig, Andreas 06763303.2 / 1 883 696 50823 Köln (DE) (71) Applicant: Direvo Biotech AG (74) Representative: von Kreisler Selting Werner 50829 Köln (DE) Patentanwälte P.O. Box 10 22 41 (72) Inventors: 50462 Köln (DE) • Koltermann, André 82057 Icking (DE) Remarks: • Kettling, Ulrich This application was filed on 14-01-2009 as a 81477 München (DE) divisional application to the application mentioned under INID code 62. (54) Serine proteases with altered sensitivity to activity-modulating substances (57) The present invention provides variants of ser- screening of the library in the presence of one or several ine proteases of the S1 class with altered sensitivity to activity-modulating substances, selection of variants with one or more activity-modulating substances. A method altered sensitivity to one or several activity-modulating for the generation of such proteases is disclosed, com- substances and isolation of those polynucleotide se- prising the provision of a protease library encoding poly- quences that encode for the selected variants.
    [Show full text]
  • Feather Protein Lysate Optimization and Feather Meal Formation Using
    www.nature.com/scientificreports OPEN Feather protein lysate optimization and feather meal formation using YNDH protease with keratinolytic activity afterward enzyme partial purifcation and characterization Doaa A. Goda1*, Ahmad R. Bassiouny2, Nihad M. Abdel Monem2, Nadia A. Soliman1 & Yasser R. Abdel‑Fattah1 Incubation parameters used for the creation of a protein lysate from enzymatically degraded waste feathers using crude keratinase produced by the Laceyella sacchari strain YNDH were optimized using the Response Surface Methodology (RSM); amino acids quantifcation was also estimated. The optimization elevated the total protein to 2089.5 µg/ml through the application of the following optimal conditions: a time of 20.2 h, a feather concentration (conc.) of 3 g%, a keratinase activity of 24.5 U/100 ml, a pH of 10, and a cultivation temperature of 50 °C. The produced Feather Protein Lysate (FPL) was found to be enriched with essential and rare amino acids. Additionally, this YNDH enzyme group was partially purifed, and some of its characteristics were studied. Crude enzymes were frst concentrated with an Amicon Ultra 10‑k centrifugal flter, and then concentrated proteins were applied to a "Q FF" strong anion column chromatography. The partially purifed enzyme has an estimated molecular masses ranging from 6 to 10 kDa. The maximum enzyme activity was observed at 70 °C and for a pH of 10.4. Most characteristics of this protease/keratinase group were found to be nearly the same when the activity was measured with both casein and keratin‑azure as substrates, suggesting that these three protein bands work together in order to degrade the keratin macromolecule.
    [Show full text]
  • Isolation, Purification, and Optimization of Thermophilic and Alkaliphilc Protease Originating from Hot Water Spring Bacteria
    Online - 2455-3891 Vol 10, Issue 9, 2017 Print - 0974-2441 Research Article ISOLATION, PURIFICATION, AND OPTIMIZATION OF THERMOPHILIC AND ALKALIPHILC PROTEASE ORIGINATING FROM HOT WATER SPRING BACTERIA ASHWINI N PUNTAMBEKAR, MANJUSHA S DAKE* Protein Biochemistry Laboratory, Dr. D. Y. Patil Biotechnology and Bioinformatics Institute, Dr. D. Y. Patil Vidyapeeth, Pune - 411 033, Maharashtra, India. Email: [email protected] Received: 05 April 2017, Revised and Accepted: 31 May 2017 ABSTRACT Objective: The main objective of this study is to investigate the industrial applications of a thermophillic alkaline protease from a hot water spring bacterial isolate “A” and to study its production, optimization, and purification. Methods: The alkaline protease was produced using shake flask studies maintaining a pH of 9.0 and a temperature of 50°C. Optimization studies of the enzyme were carried out using variable pH, temperature, organic carbon, and nitrogen sources followed by purification of the enzyme using DEAE-cellulose ion exchange chromatography technique. Stability of the enzyme was analyzed in the presence of organic solvents and surfactants. The efficiency of the enzyme in the removal of proteinaceous stains in the presence of strong detergents under extreme conditions was assessed. The fibrinolytic activity of the enzyme in dissolving the blood clot was confirmed. Results: The isolated alkaline protease was purified to homogeneity with a 16-fold increase. Media optimization studies revealed that 1% glucose and 1 % casein-induced the production of alkaline protease. The purified enzyme retained stability in the presence of ethanol, methanol, and acetone and surfactants such as 0.5% (w/v) sodium dodecyl sulfate (SDS) and 0.5% (v/v) Triton-X-100.
    [Show full text]
  • Expression, Delivery and Function of Insecticidal Proteins Expressed by Recombinant Baculoviruses
    Viruses 2015, 7, 422-455; doi:10.3390/v7010422 OPEN ACCESS viruses ISSN 1999-4915 www.mdpi.com/journal/viruses Review Expression, Delivery and Function of Insecticidal Proteins Expressed by Recombinant Baculoviruses Jeremy A. Kroemer 1,2, Bryony C. Bonning 1 and Robert L. Harrison 3,* 1 Department of Entomology, Iowa State University, Ames, IA 50011, USA; E-Mails: [email protected] (J.A.K.); [email protected] (B.C.B.) 2 Current location and contact information: Monsanto Company, 700 Chesterfield Parkway West, Chesterfield, MO 63017, USA 3 USDA-ARS Beltsville Agricultural Research Center, Invasive Insect Biocontrol & Behavior Laboratory, 10300 Baltimore Ave, Beltsville, MD 20705, USA * Author to whom correspondence should be addressed; E-Mail: [email protected]; Tel.: +1-301-504-5249; Fax: +1-301-504-5104. Academic Editor: John Burand and Madoka Nakai Received: 25 November 2014 / Accepted: 15 January 2015 / Published: 21 January 2015 Abstract: Since the development of methods for inserting and expressing genes in baculoviruses, a line of research has focused on developing recombinant baculoviruses that express insecticidal peptides and proteins. These recombinant viruses have been engineered with the goal of improving their pesticidal potential by shortening the time required for infection to kill or incapacitate insect pests and reducing the quantity of crop damage as a consequence. A wide variety of neurotoxic peptides, proteins that regulate insect physiology, degradative enzymes, and other potentially insecticidal proteins have been evaluated for their capacity to reduce the survival time of baculovirus-infected lepidopteran host larvae. Researchers have investigated the factors involved in the efficient expression and delivery of baculovirus-encoded insecticidal peptides and proteins, with much effort dedicated to identifying ideal promoters for driving transcription and signal peptides that mediate secretion of the expressed target protein.
    [Show full text]
  • (12) United States Patent (10) Patent No.: US 7,776,579 B2 Miwa Et Al
    US007776579B2 (12) United States Patent (10) Patent No.: US 7,776,579 B2 Miwa et al. (45) Date of Patent: Aug. 17, 2010 (54) METHOD OF DEGRADING HARDLY FOREIGN PATENT DOCUMENTS DEGRADABLE PROTEIN CN 12014.89 12/1998 (75) Inventors: Takehiro Miwa, Kanagawa (JP); Koji E. o: E. Nishizawa, Saitama (JP); Yoshie WO WO95/33056 12/1995 Hayashi, Saitama (JP); Manabu WO WO98, 20115 A1 5, 1998 Watanabe, Kanagawa (JP); Yuichi WO WO 98.30682 A1 * T 1998 Murayama, Ibaraki (JP); Miyako WO WO O2/O53723 A2 7, 2002 Yoshioka, Ibaraki (JP); Katsuhiro WO WO 02/083O82 A1 10, 2002 Miura, Ibaraki (JP) OTHER PUBLICATIONS (73) Assignee: Meiji Seika Kaisha, Ltd., Tokyo (JP) Genov et al., Biochem J, 1982, vol. 207, p. 193-200.* Lin et al. "Nucleotide Sequence and Expression of Kera, the Gene (*) Notice: Subject to any disclaimer, the term of this Encoding a Keartinolytic Protease of Bacillus licheniformis PWD patent is extended or adjusted under 35 I”, Applied and Environmental Microbiology, Washington, D.C., U.S.C. 154(b) by 513 days. US, vol. 61, No. 4, Apr. 1995, pp. 1469-1474, XP002042752. Yoshioka et al. “Characterization of a Proteolytic Enzyme Derived (21) Appl. No.: 10/532,605 From a Bacillus Strain That Effectively Degrades Prion Protein', Journal of Applied Microbiology Feb. 2007, vol. 102, No. Feb. 2007, (22) PCT Filed: Oct. 24, 2003 pp. 509-515, XP002422549. Linet al., App. Env, Microbiol. 1992, vol. 58, No. 10, pp. 3271-3275. (86) PCT NO.: PCT/UP03/13658 Nature, Aug. 11, 1994, pp. 471-474, vol. 370. S371 (c)(1), k cited.
    [Show full text]
  • Final Program
    In Memoriam: Final Program XXV Congress of the International Society on Thrombosis and Haemostasis and 61st Annual SSC Meeting June 20 – 25, 2015 Toronto, Canada www.isth2015.org 1 Final Program Table of Contents 3 Venue and Contacts 5 Invitation and Welcome Message 12 ISTH 2015 Committees 24 Congress Support 25 Sponsors and Exhibitors 27 ISTH Awards 32 ISTH Society Information 37 Program Overview 41 Program Day by Day 55 SSC and Educational Program 83 Master Classes and Career Mentorship Sessions 87 Nurses Forum 93 Scientific Program, Monday, June 22 94 Oral Communications 1 102 Plenary Lecture 103 State of the Art Lectures 105 Oral Communications 2 112 Abstract Symposia 120 Poster Session 189 Scientific Program, Tuesday, June 23 190 Oral Communications 3 198 Plenary Lecture 198 State of the Art Lectures 200 Oral Communications 4 208 Plenary Lecture 209 Abstract Symposia 216 Poster Session 285 Scientific Program, Wednesday, June 24 286 Oral Communications 5 294 Plenary Lecture 294 State of the Art Lectures 296 Oral Communications 6 304 Abstract Symposia 311 Poster Session 381 Scientific Program, Thursday, June 25 382 Oral Communications 7 390 Plenary Lecture 390 Abstract Symposia 397 Highlights of ISTH 399 Exhibition Floor Plan 402 Exhibitor List 405 Congress Information 406 Venue Plan 407 Congress Information 417 Social Program 418 Toronto & Canada Information 421 Transportation in Toronto 423 Future ISTH Meetings and Congresses 2 427 Authors Index 1 Thank You to Everyone Who Supported the Venue and Contacts 2014 World Thrombosis Day
    [Show full text]
  • Silver Nanoparticles: Mechanism of Action and Probable Bio-Application
    Journal of Functional Biomaterials Review Silver Nanoparticles: Mechanism of Action and Probable Bio-Application Ekaterina O. Mikhailova Institute of innovation management, Kazan National Research Technological University, K. Marx Street 68, 420015 Kazan, Russia; [email protected] Received: 17 October 2020; Accepted: 23 November 2020; Published: 26 November 2020 Abstract: This review is devoted to the medical application of silver nanoparticles produced as a result of “green” synthesis using various living organisms (bacteria, fungi, plants). The proposed mechanisms of AgNPs synthesis and the action mechanisms on target cells are highlighted. Keywords: silver nanoparticles; AgNPs; green synthesis; bio-application 1. Introduction In the modern world, “green technologies” are gaining more and more popularity due to their effectiveness, non-toxicity, and “eco-friendly”. One of the directions of “green synthesis” is the production of elementary silver nanoparticles (AgNPs) for use in various areas of human activity, primarily in medicine. It should be noted that mankind has been familiar with the bactericidal effects of Ag+ ions from time immemorial. The presence of both silver ions and AgNPs was established by the research in the solution named “Holy water”, known from the beginning of the first Millennium as a protection tool against infection by microorganisms [1]. It is thanks to the silver ions and AgNP suspension that it can have a bactericidal, bacteriostatic, antiviral, and antifungal effect on a large number of pathogenic microorganisms, yeast fungi, and viruses. In addition, the inhibitory effect can sometimes be expressed even slightly stronger in comparison with penicillin, biomycin, and other “classic” antibiotics due to the resistance of many strains of microorganisms to antibiotics [2,3].
    [Show full text]